From: G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
 | Day 1: mean (SD) (n)a | Day 3: mean (SD) (n) | Day 7: mean (SD) (n) | ||||||
---|---|---|---|---|---|---|---|---|---|
A− (males) | A | B | A− (males) | A | B | A− (males) | A | B | |
RBC × 106/µL | 4.03 (0.42) (5) | 4.1 (0.7) (7) | 4.4 (0.5) (48) | 3.7 (0.5) (5) | 3.6 (0.7) (7) | 4.1 (0.6) (48) | 3.7 (0.3) (5) | 3.9 (0.5) (6) | 4.2 (0.5) (46) |
Haemoglobin g/dL | 11.3 (1.71) (5) | 11.6 (2.0) (7) | 12.4 (1.7) (48) | 10.0 (1.3) (5) | 10.2 (1.9) (7) | 11.8 (1.7) (48) | 9.9 (1.6) (5) | 10.7 (1.9) (6) | 12.1 (1.4) (46) |
Hematocrit % | 34.5 (5.05) (5) | 35.4 (6.2) (7) | 37.5 (5.0) (48) | 30.4 (3.2) (5) | 30.9 (5.4) (7) | 36 (4.7) (48) | 29.4 (4.7) (5) | 32.1 (6.6) (6) | 36.8 (4) (46) |
Reticulocyte % | 1.1 (0.5) (3) | 1.1 (0.5) (4) | 2. 2 (1.8) (41) | 2.4 (1.3) (3) | 2.2 (1.2) (4) | 2.6 (1.9) (41) | 11.2 (9.5) (3) | 11.2 (9.5) (3) | 3.6 (2.9) (40) |
AST IU/L | 30.1 (24.2) (3) | 29.2 (19.8) (4) | 34.6 (19.7) (41) | 35.3 (7.2) (3) | 32.6 (7.9) (4) | 31.8 (21.5) (41) | 39.0 (33.9) (3) | 39.0 (33.9) (3) | 36.9 (25.4) (40) |
ALT IU/L | 33.6 (33.1) (3) | 30.3 (27.8) (4) | 37.2 (24.9) (41) | 29.4 (17) (3) | 27.1 (14.6) (4) | 37.2 (31) (41) | 120.2 (113) (3) | 120.2 (113) (3) | 52.3 (48.3) (40) |
Total bilirubin mg/dL | 1.2 (0.6) (3) | 1.1 (0.6) (4) | 1.4 (0.8) (41) | 2.0 (1.1) (3) | 1.8 (1.0) (4) | 0.9 (0.4) (41) | 0.6 (0.2) (3) | 0.6 (0.2) (3) | 0.7 (0.31) (40) |
Direct bilirubin mg/dL | 0.8 (0.6) (3) | 0.7 (0.5) (4) | 0.9 (0.7) (41) | 1.1 (0.7) (3) | 0.9 (0.7) (4) | 0.6 (0.3) (41) | 0.3 (0.1) (3) | 0.3 (0.1) (3) | 0.5 (0.2) (40) |
Indirect bilirubin mg/dL | 0.4 (0.2) (3) | 0.4 (0.2) (4) | 0.6 (0.4) (41) | 0.9 (0.7) (3) | 0.9 (0.6) (4) | 0.4 (0.3) (41) | 0.3 (0.1) (3) | 0.3 (0.1) (3) | 0.3 (0.2) (40) |
Creatinin mg/dL | 1.0 (0.2) (3) | 1.0 (0.13) (4) | 0.9 (0.1) (41) | 0.9 (0) (3) | 0.9 (0) (4) | 0.8 (0.1) (41) | 0.9 (0.1) (3) | 0.9 (0.1) (3) | 0.8 (0.2) (40) |